Discovery - University of Dundee - Online Publications

Library & Learning Centre

Assessing physicians' preferences on skin cancer treatment in Europe

Standard

Assessing physicians' preferences on skin cancer treatment in Europe. / Ferrandiz, L.; Ruiz-de-Casas, A.; Trakatelli, M.; de Vries, E.; Ulrich, M.; Aquilina, S.; Saksela, O.; Majewski, S.; Ranki, A.; Proby, C.; Magnoni, C.; Pitkanen, S.; Kalokasidis, K.; Siskou, S.; Hinrichs, B.; Altsitsiadis, E.; Stockfleth, E.; Moreno-Ramirez, D.; EPIDERM Grp.

In: British Journal of Dermatology, Vol. 167, 08.2012, p. 29-35.

Research output: Contribution to journalArticle

Harvard

Ferrandiz, L, Ruiz-de-Casas, A, Trakatelli, M, de Vries, E, Ulrich, M, Aquilina, S, Saksela, O, Majewski, S, Ranki, A, Proby, C, Magnoni, C, Pitkanen, S, Kalokasidis, K, Siskou, S, Hinrichs, B, Altsitsiadis, E, Stockfleth, E, Moreno-Ramirez, D & EPIDERM Grp 2012, 'Assessing physicians' preferences on skin cancer treatment in Europe' British Journal of Dermatology, vol 167, pp. 29-35.

APA

Ferrandiz, L., Ruiz-de-Casas, A., Trakatelli, M., de Vries, E., Ulrich, M., Aquilina, S., Saksela, O., Majewski, S., Ranki, A., Proby, C., Magnoni, C., Pitkanen, S., Kalokasidis, K., Siskou, S., Hinrichs, B., Altsitsiadis, E., Stockfleth, E., Moreno-Ramirez, D., & EPIDERM Grp (2012). Assessing physicians' preferences on skin cancer treatment in Europe. British Journal of Dermatology, 167, 29-35doi: 10.1111/j.1365-2133.2012.11084.x

Vancouver

Ferrandiz L, Ruiz-de-Casas A, Trakatelli M, de Vries E, Ulrich M, Aquilina S et al. Assessing physicians' preferences on skin cancer treatment in Europe. British Journal of Dermatology. 2012 Aug;167:29-35.

Author

Ferrandiz, L.; Ruiz-de-Casas, A.; Trakatelli, M.; de Vries, E.; Ulrich, M.; Aquilina, S.; Saksela, O.; Majewski, S.; Ranki, A.; Proby, C.; Magnoni, C.; Pitkanen, S.; Kalokasidis, K.; Siskou, S.; Hinrichs, B.; Altsitsiadis, E.; Stockfleth, E.; Moreno-Ramirez, D.; EPIDERM Grp / Assessing physicians' preferences on skin cancer treatment in Europe.

In: British Journal of Dermatology, Vol. 167, 08.2012, p. 29-35.

Research output: Contribution to journalArticle

Bibtex - Download

@article{7c759170c6394d5d8ded4bf1e49c3c41,
title = "Assessing physicians' preferences on skin cancer treatment in Europe",
author = "L. Ferrandiz and A. Ruiz-de-Casas and M. Trakatelli and {de Vries}, E. and M. Ulrich and S. Aquilina and O. Saksela and S. Majewski and A. Ranki and C. Proby and C. Magnoni and S. Pitkanen and K. Kalokasidis and S. Siskou and B. Hinrichs and E. Altsitsiadis and E. Stockfleth and D. Moreno-Ramirez and {EPIDERM Grp}",
year = "2012",
volume = "167",
pages = "29--35",
journal = "British Journal of Dermatology",
issn = "0007-0963",

}

RIS (suitable for import to EndNote) - Download

TY - JOUR

T1 - Assessing physicians' preferences on skin cancer treatment in Europe

A1 - Ferrandiz,L.

A1 - Ruiz-de-Casas,A.

A1 - Trakatelli,M.

A1 - de Vries,E.

A1 - Ulrich,M.

A1 - Aquilina,S.

A1 - Saksela,O.

A1 - Majewski,S.

A1 - Ranki,A.

A1 - Proby,C.

A1 - Magnoni,C.

A1 - Pitkanen,S.

A1 - Kalokasidis,K.

A1 - Siskou,S.

A1 - Hinrichs,B.

A1 - Altsitsiadis,E.

A1 - Stockfleth,E.

A1 - Moreno-Ramirez,D.

A1 - EPIDERM Grp

AU - Ferrandiz,L.

AU - Ruiz-de-Casas,A.

AU - Trakatelli,M.

AU - de Vries,E.

AU - Ulrich,M.

AU - Aquilina,S.

AU - Saksela,O.

AU - Majewski,S.

AU - Ranki,A.

AU - Proby,C.

AU - Magnoni,C.

AU - Pitkanen,S.

AU - Kalokasidis,K.

AU - Siskou,S.

AU - Hinrichs,B.

AU - Altsitsiadis,E.

AU - Stockfleth,E.

AU - Moreno-Ramirez,D.

AU - EPIDERM Grp

PY - 2012/8

Y1 - 2012/8

N2 - <p>Background A wide variety of both surgical and nonsurgical therapies is currently available for patients with skin cancer. Objectives This part of the EPIDERM (European Prevention Initiative for Dermatological Malignancies) project is aimed at the evaluation of the treatment preferences for skin cancer in eight countries of the European Union. Methods A multicentre hospital-based casecontrol study was carried out at dermatology departments in Finland, Germany, Greece, Italy, Malta, Poland, Scotland and Spain. Patients with skin cancer (basal cell carcinoma, actinic keratosis, squamous cell carcinoma, cutaneous malignant melanoma and Bowen disease) were consecutively enrolled between July 2008 and July 2010. Information on the study variables (sex, age, country, tumour type, anatomical location and treatment) was obtained from questionnaires designed by the EPIDERM project. Results In total, 1708 patients with skin cancer were included. Surgery was the first treatment option in 76.5% of the patients (P = 0.001). Actinic keratosis was the only tumour type in which nonsurgical treatment was more frequent than surgery (91.4%). Tumours on the head were less likely to be surgically excised than those at other locations (odds ratio 0.25, P = 0.001). Simple excision or curettage was the most common surgical procedure (65.4%), followed by graft and flaps (22.4%). Cryotherapy was the most common nonsurgical option (52.4%), followed by imiquimod (18.0%), photodynamic therapy (PDT; 12.0%), 5-fluorouracil (5-FU; 5.7%), and diclofenac with hyaluronic acid (4.0%). Conclusions Surgery remains the first-choice treatment of skin cancer. Regarding nonsurgical treatments, the conservative treatments available (imiquimod, 5-FU, PDT and diclofenac gel) have not yet exceeded the use of ablative options such as cryotherapy despite their accepted benefit of treating field cancerization.</p>

AB - <p>Background A wide variety of both surgical and nonsurgical therapies is currently available for patients with skin cancer. Objectives This part of the EPIDERM (European Prevention Initiative for Dermatological Malignancies) project is aimed at the evaluation of the treatment preferences for skin cancer in eight countries of the European Union. Methods A multicentre hospital-based casecontrol study was carried out at dermatology departments in Finland, Germany, Greece, Italy, Malta, Poland, Scotland and Spain. Patients with skin cancer (basal cell carcinoma, actinic keratosis, squamous cell carcinoma, cutaneous malignant melanoma and Bowen disease) were consecutively enrolled between July 2008 and July 2010. Information on the study variables (sex, age, country, tumour type, anatomical location and treatment) was obtained from questionnaires designed by the EPIDERM project. Results In total, 1708 patients with skin cancer were included. Surgery was the first treatment option in 76.5% of the patients (P = 0.001). Actinic keratosis was the only tumour type in which nonsurgical treatment was more frequent than surgery (91.4%). Tumours on the head were less likely to be surgically excised than those at other locations (odds ratio 0.25, P = 0.001). Simple excision or curettage was the most common surgical procedure (65.4%), followed by graft and flaps (22.4%). Cryotherapy was the most common nonsurgical option (52.4%), followed by imiquimod (18.0%), photodynamic therapy (PDT; 12.0%), 5-fluorouracil (5-FU; 5.7%), and diclofenac with hyaluronic acid (4.0%). Conclusions Surgery remains the first-choice treatment of skin cancer. Regarding nonsurgical treatments, the conservative treatments available (imiquimod, 5-FU, PDT and diclofenac gel) have not yet exceeded the use of ablative options such as cryotherapy despite their accepted benefit of treating field cancerization.</p>

U2 - 10.1111/j.1365-2133.2012.11084.x

DO - 10.1111/j.1365-2133.2012.11084.x

M1 - Article

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

VL - 167

SP - 29

EP - 35

ER -

Documents

Library & Learning Centre

Contact | Accessibility | Policy